ArticleThe journal of medicine access
Prevalence of anemia and years lived with disability in eastern Sub-Saharan Africa, 1990 to 2023.
Article in The journal of medicine access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anemia remains a significant public health challenge in the Eastern Sub-Saharan Africa region, contributing to substantial morbidity and adverse outcomes across the lifespan. Understanding trends in the prevalence anemia due to all causes and the years lived with disability is critical for informing targeted interventions and strengthening health systems in the region. Methods: This study followed the methodological framework of the Global Burden of Disease 2023 study to estimate the prevalence of anemia and the years lived with disability in the Eastern Sub-Saharan African region from 1990 to 2023. Data were synthesized from a broad range of sources, including population-based surveys, antenatal clinic records, hospital registries, and demographic surveillance systems. Bayesian meta-regression tool for disease modeling (DisMod-MR 2.1) was used to estimate prevalence and years lived with disability. Estimates were stratified by age, sex, and locations, ensuring internal consistency over time and across subpopulations. All estimates were reported with 95% uncertainty intervals. Results: The age-standardized prevalence of anemia due to all causes was estimated to be 38,264 cases per 100,000 population (95% UI: 32,886-46,273), and the age-standardized years lived with disability was 1,247 years lived with disability per 100,000 population (95% UI: 787-2,015). Mild anemia (19.9% (95% UI: 15.6-27.3)) and moderate anemia (16.7% (95% UI: 13.5-20.2)) contributed higher share of the prevalence, whereas moderate anemia contributed the most for the years lived with disability (7% (95% UI: 5.4-9.3)). Conclusion: This study has underscores that the prevalence of anemia due to all causes and the years lived with disability were high in the Eastern Sub-Saharan African region, with under-five children disproportionately affected and stagnant trend over the past three decades. Strengthening nutrition programs, improving access to healthcare services, and implementing context-specific strategies are critical to accelerating progress toward anemia reduction in the region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.